Publication | Closed Access

Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): Correlations with disease activity and severity of joint damage (a multicenter trial)

InflammationRheumatologyJoint DamageAutoimmune DiseaseRheumatic DiseasesJuvenile Idiopathic ArthritisImmunologyPsoriatic ArthritisOsteoarthritisInflammatory MarkerAutoimmunityInflammatory Rheumatic DiseaseDisease ActivityImmunotherapyMedicineSystemic Juvenile Idiopathic Arthritis